Wakestream Ventures — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
AOBiomeaobiome.comin𝕏Sep 2015
AOBiome Therapeutics is a late-stage biotechnology company developing microbiome-based treatments for inflammatory skin conditions such as atopic dermatitis and pruritus.
BiotechDigital HealthHealthtechWellness & FitnessCambridge, US
James Heywood(Manager of Issuer)Spiros Jamas(Chief Executive Officer and Manager of Issuer)Walter G. Thompson(Manager)
BoardLeonard Barshack(Manager of Issuer)Walter Thompson(Manager of Issuer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.